NCT01481597 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers


Sponsors: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	Phases: Phase I
Indications	Acronym:
Healthy
Age Groups: Adult	Gender: Both
Names: Drug: deuteporfin Drug: deuteporfin Drug: deuteporfin Drug: deuteporfin Drug: deuteporfin Drug: placebo	Enrollment: 42

Additional information about NCT01481597.